Description

VOVERAN D TAB (1X10)

Indications

VOVERAN D TAB is primarily indicated for the management of pain and inflammation associated with various conditions such as osteoarthritis, rheumatoid arthritis, and other musculoskeletal disorders. It is also used to alleviate pain from dental procedures, surgical interventions, and menstrual cramps. The combination of diclofenac and the antacid component helps to reduce gastrointestinal discomfort often associated with non-steroidal anti-inflammatory drugs (NSAIDs).

Mechanism of Action

VOVERAN D TAB contains diclofenac, which is a non-steroidal anti-inflammatory drug (NSAID). It works by inhibiting the activity of cyclooxygenase (COX) enzymes, which are crucial in the biosynthesis of prostaglandins. Prostaglandins are mediators of inflammation, pain, and fever. By reducing their production, diclofenac effectively alleviates pain and inflammation. The antacid component in VOVERAN D TAB helps to neutralize stomach acid, providing a protective effect against gastrointestinal irritation that may be caused by NSAIDs.

Pharmacological Properties

The pharmacokinetics of diclofenac involves rapid absorption from the gastrointestinal tract, with peak plasma concentrations occurring within 1 to 2 hours after oral administration. It is extensively metabolized in the liver, primarily through cytochrome P450 enzymes, and is excreted via urine. The half-life of diclofenac is approximately 1 to 2 hours, although its anti-inflammatory effects can last longer due to its active metabolites. The antacid component enhances the tolerability of the drug, reducing the risk of gastrointestinal side effects.

Contraindications

VOVERAN D TAB is contraindicated in patients with a known hypersensitivity to diclofenac or any other components of the formulation. It should not be used in individuals with a history of severe gastrointestinal bleeding, peptic ulcer disease, or those with renal impairment. Additionally, it is contraindicated in patients with active or suspected bleeding disorders and during the third trimester of pregnancy due to potential risks to the fetus.

Side Effects

Common side effects associated with VOVERAN D TAB include gastrointestinal disturbances such as nausea, vomiting, diarrhea, constipation, and abdominal pain. Other potential side effects may include headache, dizziness, and skin rashes. Serious adverse effects, although rare, can include liver dysfunction, renal impairment, and cardiovascular events such as myocardial infarction or stroke. Patients should be monitored for any unusual symptoms and advised to report them promptly to their healthcare provider.

Dosage and Administration

The recommended dosage of VOVERAN D TAB varies based on the specific condition being treated and the patient’s response to therapy. Generally, the initial dose for adults is 50 mg to 75 mg taken two to three times daily. For chronic conditions, a maintenance dose may be adjusted based on efficacy and tolerability, not exceeding 150 mg per day. VOVERAN D TAB should be taken with food to minimize gastrointestinal side effects and enhance absorption. It is essential for patients to adhere to the prescribed dosage and not to exceed the recommended daily intake.

Interactions

VOVERAN D TAB may interact with other medications, potentially altering their effects. Concurrent use with other NSAIDs, anticoagulants, or corticosteroids can increase the risk of gastrointestinal bleeding. Additionally, diclofenac may enhance the effects of anticoagulants such as warfarin, necessitating careful monitoring of coagulation parameters. It is also important to note that the use of diclofenac with certain antihypertensive agents may diminish their effectiveness. Patients should inform their healthcare provider of all medications, including over-the-counter drugs and supplements, prior to starting VOVERAN D TAB.

Precautions

Before initiating treatment with VOVERAN D TAB, a thorough medical history should be obtained, particularly regarding any history of gastrointestinal disorders, cardiovascular disease, liver or renal impairment, and asthma. Caution should be exercised in elderly patients, as they may be more susceptible to the adverse effects of NSAIDs. Regular monitoring of renal function and liver enzymes is recommended during prolonged therapy. Patients should be advised to avoid alcohol consumption during treatment, as it may exacerbate gastrointestinal side effects.

Clinical Studies

Clinical studies have demonstrated the efficacy of diclofenac in reducing pain and inflammation in various musculoskeletal disorders. Research has shown that patients receiving diclofenac report significant improvements in pain scores and functional outcomes compared to placebo. Additionally, studies have indicated that the combination of diclofenac with an antacid may enhance gastrointestinal tolerability, making it a preferable option for patients at risk of NSAID-related gastrointestinal complications. Further research is ongoing to evaluate the long-term safety and effectiveness of VOVERAN D TAB in diverse patient populations.

Conclusion

VOVERAN D TAB is a valuable therapeutic option for managing pain and inflammation associated with various conditions. Its dual-action formulation not only alleviates pain but also minimizes gastrointestinal side effects, making it suitable for a broader range of patients. However, as with any medication, it is crucial for patients to use VOVERAN D TAB responsibly, adhering to prescribed dosages and monitoring for any adverse effects. Consultation with a healthcare provider is essential for optimizing treatment outcomes and ensuring safety.